stockrow
Saturday 7 November 2026
Export CNTB’s income statement to Excel — free account
Connect Biopharma Holdings Limited Sponsored ADR
CNTB Healthcare Biotechnology
Connect Biopharma Holdings Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $64,000.00, down 99.8% from fiscal 2024.
- Revenue
- +296.6%
- EPS
- −17.4%
- Free cash flow
- −23.5%
- Total debt
- −61.0%
Quarter to June 2026, against a year earlier
0.73
0.00
0.00%
Follow CNTB
Alert me
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) P/E ratio
Connect Biopharma Holdings Limited Sponsored ADR has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| 2 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| IBIO iBio, Inc. compare | n/m |
| HOWL Werewolf Therapeutics, Inc. compare | n/m |
| MREO Mereo BioPharma Group plc - Sponsored ADR compare | n/m |
| APLM Apollomics Inc. compare | n/m |
| CRBU Caribou Biosciences, Inc. compare | n/m |
| IMA ImageneBio, Inc. compare | n/m |
| HYFT MindWalk Holdings Corp. compare | n/m |
| TIL Instil Bio, Inc. compare | n/m |
| CNTB Connect Biopharma Holdings Limited Sponsored ADR | n/m |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)